Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02565212Phase 4Completed
A Phase 4 trial of montelukast, mometasone in allergic rhinitis (AR), sponsored by Istanbul Education Research Hospital. Started May 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02565212.